{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 460023267
| IUPAC_name = (6''R'',7''R'')-7-{[(2''E'')-2-(2-amino-1,3-thiazol-4-yl)-<br>2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol-<br>5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]<br>oct-2-ene-2-carboxylic acid
| image = Cefmenoxime.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|cefmenoxime}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration = Intramuscular, [[Intravenous therapy|intravenous]]
<!--Pharmacokinetic data-->
| bioavailability = 100% (given [[Intramuscular injection|IM]])
| protein_bound = 50% to 70%
| metabolism = Negligible
| elimination_half-life = 1 hour
| excretion = [[Kidney|Renal]], unchanged
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 65085-01-0
| ATC_prefix = J01
| ATC_suffix = DD05
| ATC_supplemental =  
| PubChem = 9570757
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00267
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 7845223
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = KBZ4844CXN
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07641
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 55490
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201224
<!--Chemical data-->
| C=16 | H=17 | N=9 | O=5 | S=3
| molecular_weight = 511.562 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)CSc4nnnn4C)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HJJDBAOLQAWBMH-YCRCPZNHSA-N
}}
'''Cefmenoxime''' is a third-generation [[cephalosporin]] [[antibiotic]].

==External links==
* {{DiseasesDB|30892}}
* {{cite journal | vauthors = Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T | title = Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis | journal = Jpn J Antibiot | volume = 48 | issue = 5 | pages = 602–9 | year = 1995 | pmid = 7637194}}
* {{cite journal | vauthors = Paladino J, Fell R | title = Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia. | journal = Ann Pharmacother | volume = 28 | issue = 3 | pages = 384–9 | year = 1994 | pmid = 8193431 | doi = 10.1177/106002809402800316 }}
* {{cite journal | vauthors = Duncker G, Reich U, Krausse R | title = Cefmenoxime in corneal organ culture. | journal = Ophthalmologica | volume = 208 | issue = 5 | pages = 262–6 | year = 1994 | pmid = 7816419 | doi = 10.1159/000310505}}

{{CephalosporinAntiBiotics}}

[[Category:Acetaldehyde dehydrogenase inhibitors]]
[[Category:Thiazoles]]
[[Category:Tetrazoles]]
[[Category:Cephalosporin antibiotics]]
[[Category:Oximes]]


{{antibiotic-stub}}